SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,378,380 | +65.4% | 102,115 | +53.1% | 0.01% | +44.4% |
| Q2 2023 | $7,484,388 | +41206.8% | 66,682 | -49.9% | 0.01% | -69.0% |
| Q1 2023 | $18,119 | +64.7% | 133,198 | +56.9% | 0.03% | +81.2% |
| Q4 2022 | $11,004 | -99.8% | 84,917 | +107.0% | 0.02% | +128.6% |
| Q3 2022 | $4,498,000 | +79.1% | 41,025 | +25.8% | 0.01% | +75.0% |
| Q2 2022 | $2,512,000 | +49.3% | 32,600 | +52.3% | 0.00% | +100.0% |
| Q1 2022 | $1,682,000 | -72.6% | 21,400 | -68.4% | 0.00% | -75.0% |
| Q4 2021 | $6,144,000 | -14.5% | 67,821 | -16.2% | 0.01% | -11.1% |
| Q3 2021 | $7,188,000 | +41.7% | 80,972 | +25.8% | 0.01% | +12.5% |
| Q2 2021 | $5,071,000 | -49.4% | 64,343 | -53.1% | 0.01% | -46.7% |
| Q1 2021 | $10,022,000 | -58.2% | 137,109 | -1.8% | 0.02% | -59.5% |
| Q4 2020 | $23,959,000 | +27.2% | 139,668 | +4.8% | 0.04% | -19.6% |
| Q3 2020 | $18,833,000 | -18.5% | 133,300 | -6.1% | 0.05% | -27.0% |
| Q2 2020 | $23,106,000 | +37.0% | 142,001 | -17.1% | 0.06% | +23.5% |
| Q1 2020 | $16,868,000 | -47.5% | 171,213 | -31.3% | 0.05% | -34.6% |
| Q4 2019 | $32,107,000 | -26.3% | 249,300 | -31.8% | 0.08% | -38.1% |
| Q1 2019 | $43,588,000 | +5.3% | 365,700 | -4.7% | 0.13% | +7.7% |
| Q4 2018 | $41,407,000 | -51.3% | 383,893 | -27.0% | 0.12% | -36.8% |
| Q3 2018 | $84,961,000 | +248.8% | 526,045 | +60.0% | 0.18% | +224.6% |
| Q2 2018 | $24,361,000 | 0.0% | 328,805 | 0.0% | 0.06% | 0.0% |
| Q1 2018 | $24,361,000 | -17.6% | 328,805 | -38.1% | 0.06% | -46.7% |
| Q4 2017 | $29,562,000 | -13.7% | 531,316 | -29.6% | 0.11% | -17.7% |
| Q3 2017 | $34,252,000 | +128.8% | 755,118 | +68.3% | 0.13% | +88.4% |
| Q2 2017 | $14,968,000 | +0.8% | 448,560 | -12.4% | 0.07% | -15.9% |
| Q1 2017 | $14,855,000 | +38.5% | 512,075 | +31.0% | 0.08% | +54.7% |
| Q4 2016 | $10,725,000 | -68.3% | 391,000 | -29.5% | 0.05% | -66.2% |
| Q3 2016 | $33,827,000 | +205.4% | 554,706 | -6.6% | 0.16% | +153.2% |
| Q2 2016 | $11,076,000 | – | 593,600 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |